Alakor is inhibitor of free radical processes, a membranoprotektor, renders anti-hypoxemic, a stress tire-tread, nootropic, anticonvulsant and anxiolytic action. Drug increases resistance of an organism to influence of various harmful factors, to kisnevozalezhny morbid conditions (shock, a hypoxia and ischemia, violations of cerebral circulation, intoxication alcohol and antipsychotic means (neuroleptics)).

Drug improves brain metabolism and blood supply of a brain, improves microcirculation and rheological properties of blood, reduces aggregation of platelets. Stabilizes membrane structures of blood cells (erythrocytes and platelets) at hemolysis. Has hypolipidemic effect , content of the general cholesterol and lipoproteids of the low density (LDL) reduces. Reduces enzymatic a toxaemia and endogenous intoxication at sharp pancreatitis.

Indication

• Acute disorders of cerebral circulation;
• craniocereberal injury, consequences of craniocereberal injuries;
• distsirkulyatorny encephalopathy;
• syndrome of vegetative dystonia;
• easy cognitive violations of atherosclerotic genesis;
• anxiety disorders at neurotic and neurosis-like states;
• a sharp myocardial infarction (since the first day), as a part of complex therapy;
• primary open angle glaucoma of various stages, as a part of complex therapy;
• knocking over of an abstinence syndrome at alcoholism with prevalence of neurosis-like and vegetovascular frustration;
• sharp intoxication antipsychotic means;
• sharp pyoinflammatory processes in an abdominal cavity (sharp necrotic pancreatitis, peritonitis) as a part of complex therapy.

Structure

Active ingredient: ethylmethylhydroxypyridine succinate.

1 ml of ethylmethylhydroxypyridine succinate in terms of 100% substance - 50 mg.

Excipients: sodium metabisulphite (E 223), water for injections.

Contraindication

Acute liver or renal failure, hypersensitivity to drug, children's age, pregnancy, the feeding period a breast.

Route of administration

Alakor is appointed intramusculary or intravenously (struyno, by drop infusion). Doses select individually. At an infusional method of administration medicine should be dissolved in normal saline solution of sodium of chloride (200 ml). Begin treatment of adults with a dose of 50-100 mg 1-3 times a day, gradually raising a dose to obtaining therapeutic effect. Struyno Alakor enter slowly within 5-7 minutes, by drop infusion - with a speed of 40-60 thaws of 1 minute. The maximum daily dose should not exceed 1200 mg.

Pregnant

Alakor is contraindicated to

Feature

Strictly controlled clinical trials of safety of use of medicine for children were not conducted by

therefore Alakor it is contraindicated to this category of patients to apply.

Drivers

during treatment needs to be careful at control of motor transport or work with mechanisms, considering the probability of side effects which can influence the speed of response and ability to concentrate attention.

Overdose

Symptoms: drowsiness, insomnia.

Treatment: in connection with hypotoxicity of overdose it is improbable. Treatment is usually not necessary, symptoms pass independently within a day. At the significant manifestations the supporting and symptomatic treatment is carried out.

Side effects

from the immune system: very seldom - an acute anaphylaxis, a Quincke's disease, a small tortoiseshell frequency is unknown - allergic reactions, hyperaemia, heavy reactions of hypersensitivity are possible.

Mental violations: very seldom - drowsiness frequency is unknown - backfilling process violation, feeling of alarm, emotional reactivity.

from a cardiovascular system: frequency is unknown - heartbeat, tachycardia.

from nervous system: very seldom - a headache, dizziness (it can be connected with excessively high rate of administering and have short-term character); frequency is unknown - a lack of coordination, a tremor.

from vessels: very seldom - decrease in the ABP, increase in the ABP (it can be connected with excessively high rate of administering and have short-term character).

from the respiratory system, bodies of a thorax and mediastinum: very seldom - dry cough, irritation in a throat, discomfort in a thorax, breath difficulty (it can be connected with excessively high rate of administering and have short-term character); frequency is unknown - a bronchospasm.

from digestive tract: very seldom - dryness in a mouth, nausea, feeling of an unpleasant smell, metal smack in a mouth the frequency is unknown - dispepsichesky frustration, diarrhea.

from skin and hypodermic fabrics: very seldom - an itch, rash, hyperaemia of the person; frequency is unknown - a distal hyperhidrosis.

General violations and reactions in the injection site: very seldom - caumesthesia; frequency is unknown - changes in the injection site.

Interaction

Alakor strengthens effect of benzodiazepine anxiolytics, anticonvulsants (carbamazepine), protivoparkinsonichesky means (levodopa). Reduces toxic effect of alcohol.

to Store

in original packing at a temperature not above 25 °C. To store out of children's reach.

Expiration date: 2 years.